Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.This transaction
Transfer of all shares of FKRCounterpartyINTELLECTUAL DATA CO., LTD.
Disclosing companyFRONTEO,Inc.
Execution Date / Effective Date21 July 2026 (transferred)
Target company
Legal tech AI business (e-discovery support)
Location South Korea
Impact on Business Performance
Already reflected in the consolidated earnings forecasts for the fiscal year ending March 2027, and the impact on net sales, expenses and other items is immaterial.
Procedures and assumptions
Management structure after acquisitionFollowing the transfer, e-discovery support services in Korea are expected to continue to be provided by the transferee, with no change in the services provided to customers. The corporate name, representative and treatment of employees: Not disclosed
| Item | Details |
|---|---|
| Transaction name | Transfer of all shares of FKR |
| Counterparty name | INTELLECTUAL DATA CO., LTD. |
| Name of the Subject Company | FRONTEO Korea, Inc. |
| Business Description of the Subject Company | Legal tech AI business (e-discovery support) |
| Location of the Subject Company | South Korea |
| Number of shares acquired | All shares (specific number of shares: Not disclosed) / Number of voting rights: Not disclosed |
| Impact on Business Performance | Already reflected in the consolidated earnings forecasts for the fiscal year ending March 2027, and the impact on net sales, expenses and other items is immaterial. |
| Execution Date / Effective Date | 21 July 2026 (transferred) |
| Management structure after acquisition | Following the transfer, e-discovery support services in Korea are expected to continue to be provided by the transferee, with no change in the services provided to customers. The corporate name, representative and treatment of employees: Not disclosed |
Items this document does not state (23)
Capital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To optimize its business portfolio and concentrate management resources on its life sciences AI business, which it regards as the core of its future growth strategy. FRONTEO also determined that continuing the business under the transferee would contribute to the growth of FRONTEO Korea, Inc. and the expansion of its business in the Korean market.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.